MassachusettsH 1379194th General Court (2025-2026)House

An Act exempting medications used for the treatment of opioid use disorder from the prior approval process under the Massachusetts Medicaid program

Sponsored By: Michael P. Kushmerek (Democratic)

In Committee

Health Care FinancingHouse Ways and Means

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Michael P. Kushmerek

    Democratic • House

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

All Roll Calls

Yes: 13 • No: 0

committee vote 4/9/2026

Committee Favorable: Favorable Report

Yes: 13 • No: 0

Actions Timeline

  1. Bill reported favorably by committee and referred to the committee on House Ways and Means

    4/16/2026House
  2. Reporting date extended to Monday, June 15, 2026

    3/19/2026House
  3. Reporting date extended to Wednesday, March 18, 2026

    9/15/2025House
  4. Hearing scheduled for 07/01/2025 from 10:00 AM-12:30 PM in Gardner Auditorium

    6/24/2025legislature
  5. Senate concurred

    2/27/2025Senate
  6. Referred to the committee on Health Care Financing

    2/27/2025House

Bill Text

Related Bills

Back to State Legislation